Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by Revelation Biosciences, Inc. Revelation Biosciences, Inc. Announces Financial Results for the Three and Six Months Ended June 30, 2024 August 09, 2024 From Revelation Biosciences, Inc. Via Business Wire Tickers REVB Revelation Biosciences Announces Phase 1 Clinical Study of Gemini Met the Primary Safety Endpoint and Showed Statistically Significant Biomarker Activity June 24, 2024 From Revelation Biosciences, Inc. Via Business Wire Tickers REVB Revelation Biosciences Has Completed Dosing of its First in Human Phase 1 Clinical Study of Gemini June 13, 2024 From Revelation Biosciences, Inc. Via Business Wire Tickers REVB Revelation Biosciences, Inc. Announces Financial Results for the Three Months Ended March 31, 2024 May 10, 2024 From Revelation Biosciences, Inc. Via Business Wire Tickers REVB Revelation Biosciences, Inc. Announces Financial Results for the Three and Twelve Months Ended December 31, 2023 March 22, 2024 From Revelation Biosciences, Inc. Via Business Wire Tickers REVB Revelation Biosciences, Inc. Announces Financial Results for the Three and Nine Months Ended September 30, 2023 November 13, 2023 From Revelation Biosciences, Inc. Via Business Wire Tickers REVB Revelation Biosciences Inc. Announces Pricing of $5 Million Public Offering July 26, 2022 From Revelation Biosciences, Inc. Via GlobeNewswire Tickers REVB REVBW Revelation Biosciences, Inc., a Life Sciences Company Developing Therapeutics and Diagnostics for Respiratory Viral Infections, Including COVID-19, to Become Publicly Traded Through a Merger with Petra Acquisition, Inc. August 30, 2021 From Revelation Biosciences, Inc. Via Business Wire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.